|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||
| Condition | Onset Date / Period | Status |
|---|---|---|
| Acute bacterial sinusitis | 15-Jul-2025 | active |
| Carcinoma in situ of prostate | 19-Nov-2014 | active |
| Neoplasm of prostate | 19-Nov-2014 | active |
| Anemia | 23-Apr-2014 | active |
| Proteinuria due to type 2 diabetes mellitus | 01-May-2013 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 07-Oct-2009 | active |
| Ischemic heart disease | 01-Oct-2008 | active |
| Disorder of kidney due to diabetes mellitus | 14-Sep-2005 | active |
| Acute ST segment elevation myocardial infarction | 14-Feb-2003 | active |
| Sleep apnea | 08-Dec-1976 | active |
| Sleep disorder | 22-Nov-1976 | active |
| Essential hypertension | 24-Mar-1976 | active |
| Acute viral pharyngitis | 25-Nov-2023 - 06-Dec-2023 | inactive |
| Fracture of clavicle | 16-Sep-2023 - 18-Nov-2023 | inactive |
| Fracture of bone | 16-Sep-2023 - 18-Nov-2023 | inactive |
| Viral sinusitis | 03-Nov-2021 - 26-Nov-2021 | inactive |
| Acute bronchitis | 21-Jun-2019 - 04-Jul-2019 | inactive |
| Fracture of bone | 30-Nov-2016 - 26-Jan-2017 | inactive |
| Closed fracture of hip | 30-Nov-2016 - 26-Jan-2017 | inactive |
| Chronic kidney disease stage 4 | 05-Nov-2014 - 21-Jun-2017 | inactive |
| Chronic kidney disease stage 3 | 01-May-2013 - 21-Jun-2017 | inactive |
| Chronic kidney disease stage 2 | 07-Oct-2009 - 21-Jun-2017 | inactive |
| Chronic kidney disease stage 1 | 14-Sep-2005 - 21-Jun-2017 | inactive |
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2025-02-26 | - | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Lisinopril 10 mg oral tablet | 2025-02-26 | - | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
| Tacrolimus 1 mg prolonged-release oral tablet | 2025-02-26 | - | 1 tablet (1 mg) once daily | History of renal transplant (situation) |
| Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | 2008-10-08 | - | 1 tablet (75 mg) by mouth once daily | - |
| Simvastatin 20 mg oral tablet | 2008-10-08 | - | 1 tablet (20 mg) by mouth once daily | - |
| Nitroglycerin 400 microgram/actuation sublingual spray | 2008-10-08 | - | 400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes | - |
| Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 2008-10-08 | - | 1 tablet (100 mg) once daily | - |
| Aspirin 81 mg gastro-resistant oral tablet | 2003-02-14 | - | 1 tablet (81 mg) by mouth once daily | - |
| Atorvastatin (as atorvastatin calcium) 20 mg oral tablet | 2003-02-14 | - | 1 tablet (20 mg) once daily | - |
| Metoprolol tartrate 25 mg oral tablet | 2003-02-14 | - | 1 tablet (25 mg) by mouth twice daily | - |
| Nicotine 291.667 microgram/hour prolonged-release transdermal patch | 1962-02-07 | - | Apply one patch (291.667 microgram/hour) once daily | - |
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 26-Feb-2025 |
| SARS-CoV-2 mRNA vaccine | 24-Feb-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 28-Nov-2018 |
| Procedure | Date | Reason |
|---|---|---|
| Plain X-ray of clavicle | 16-Sep-2023 | - |
| Admission to orthopedic department | 16-Sep-2023 | Fracture of clavicle (disorder) |
| Bone density scan | 16-Sep-2023 | Fracture of clavicle (disorder) |
| Patient discharge | 29-Jan-2022 | - |
| Hospice care | 28-Jan-2022 | - |
| Notifications | 08-Dec-2021 | - |
| Certification procedure | 08-Dec-2021 | - |
| Initial patient assessment | 08-Dec-2021 | - |
| Development of individualized plan of care | 08-Dec-2021 | - |
| Screening for substance abuse | 20-Oct-2021 | - |
| Assessment of health and social care needs | 20-Oct-2021 | - |
| Screening for domestic abuse | 20-Oct-2021 | - |
| Assessment of substance use | 20-Oct-2021 | - |
| Sleep apnea assessment | 03-Jul-2019 | Sleep disorder (disorder) |
| Assessment using Morse Fall Scale | 03-Jul-2019 | - |
| Transplantation of kidney regime | 23-Jun-2017 | History of renal transplant (situation) |
| Transplant of kidney | 21-Jun-2017 | Awaiting transplantation of kidney (situation) |
| Pretransplant evaluation of kidney recipient | 21-Jun-2017 | Awaiting transplantation of kidney (situation) |
| Plain X-ray of pelvis | 30-Nov-2016 | - |
| No known allergies or intolerances |
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Cancer care plan | 19-Nov-2014 | Neoplasm of prostate (disorder) |
|
||
| Dialysis care plan | 26-Apr-2014 | - |
| Discharge care plan | 14-Feb-2003 | - |
| Lifestyle education regarding hypertension | 24-Mar-1976 | Essential hypertension (disorder) |
|
||
| Care plan | 07-Feb-1962 | Sleep apnea (disorder) |
|
||
| Immunization Recommendation | Due Date | Reason |
| Influenza virus antigen only vaccine product | 01-Oct-2026 | Annual seasonal influenza vaccination |
| Vital Signs | 2025-02-26 | 2024-02-21 |
|---|---|---|
| Body Height | 175.4 cm | 175.4 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 {score} | 1 {score} |
| Body Weight | 92.9 kg | 92.9 kg |
| Body mass index (BMI) [Ratio] | 30.2 kg/m2 | 30.2 kg/m2 |
| Heart rate | 98 /min | 68 /min |
| Respiratory rate | 14 /min | 14 /min |
| Blood pressure panel with all children optional | 82 mm[Hg] | 85 mm[Hg] |
| Recent Lab Observations | 15-FEB-2023 | Reference Range | Unit |
|---|---|---|---|
| Cholesterol [Mass/volume] in Serum or Plasma | 206.8 H | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 115.9 | 0 - 149 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 154.2 H | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 29.5 L | 40 - 60 | mg/dL |
| Device | Date (since) |
|---|---|
| Home continuous positive airway pressure unit (physical object) | 26-Feb-2025 |
| Respiratory humidifier (physical object) | 26-Feb-2025 |